Correction: Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma

Publisher Website

7 September 2021

journal article
correction
Published by Springer Science and Business Media LLC in Oncogene

Vol. 40 (41), 6057
https://doi.org/10.1038/s41388-021-01996-y

Abstract

No abstract available

This publication has 1 reference indexed in Scilit:

Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma
Oncogene, 2020